HanAll Advancing Novel Dry Eye Contender Despite Mixed Top-Line

First Phase III Trial Misses Primary Endpoint

Eye drops
HanAll Has High Hopes For HL036 Despite Mixed Results • Source: Shutterstock

More from Sensory

More from Therapy Areas